Catalyst Wire Dossier Catalyst Wire Dossier

Nalbuphine hydrochloride

nalbuphine hydrochloride · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

32 regulatory and trial events tracked for Nalbuphine hydrochloride, covering 2007-11-30 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

See pricing